Search results for "spike protein persistence"

claim, fertility impact allegation, clinical trial audit demand, regulatory malfeasance assertion, spike protein persistence, DNA contamination claim, SV40 promoter concern, spike detox protocol Included in protein mitigation approaches. protein toxicity and persistence. protein, while acknowledging the absence of large randomized trials. 🔎 How to Search the Transcript

change, biodistribution studies absence, pharmacokinetics requirement, lipid nanoparticle toxicity, spike protein persistence, transplacental passage concern, breast milk RNA detection, SV40 promoter issue, mRNA platforms, which involve injection of synthetic genetic material directing host cells to produce spike protein. Her testimony also addressed reported biodistribution of lipid nanoparticles and spike protein throughout

Berset charges, abuse of office allegation, informed consent claim, lipid nanoparticle toxicity claim, spike protein persistence, Dr. Najadi also described undergoing laboratory testing in Germany, which he stated showed persistent spike protein and alleged toxic effects from lipid nanoparticles. involvement in civil litigation filed in New York State against Pfizer, arguing that U.S. constitutional protections

Witness Testimony Keywords from Transcript protein kinase research, spike protein signaling, lipid nanoparticle delivery, biodistribution variability, mRNA translation persistence, off-target cellular effects, inflammatory One Line Summary UBC biomedical scientist analyzes spike protein signaling effects and raises concerns He explained that spike protein is biologically active and capable of interacting with cellular signaling He raised concerns regarding variability in mRNA translation levels, persistence of spike protein expression

Witness Testimony Keywords from Transcript mRNA integrity variation, spike protein isoforms, translation thrombocytopenia case, lipid nanoparticle inflammation, biodistribution organs, breast milk transfer, RNA persistence He further presented data suggesting variability in spike protein expression among individuals, including Linard described laboratory findings indicating that spike protein isoforms may be produced due to glycosylation and translation variability, and that RNA persistence could last longer than initially expected.

protein cytotoxicity, lipid nanoparticle biodistribution, ovarian accumulation concern, clotting pathway protein toxicity, lipid nanoparticle distribution, and potential genomic and clotting effects. protein production may persist in multiple tissues. harm involving ACE2 binding, renin–angiotensin system dysregulation, clotting cascade disruption, and persistent spike-mediated inflammation.

Testimony Keywords from Transcript virology expertise, viral evolution theory, mRNA platform concerns, spike protein toxicity, lipid nanoparticle delivery, biodistribution issues, immune imprinting hypothesis, novel gene-based platform utilizing lipid nanoparticles to deliver genetic instructions encoding the spike protein. He raised questions about biodistribution, persistence of spike protein expression, and potential unintended

Several mechanisms were proposed by the experts to explain how DNA contamination and the spike protein could contribute to health risks: Interference with DNA Repair Mechanisms : The spike protein has been IgG4 Shift : Continuous exposure to the spike protein might cause the body to shift its immune response Shedding and Transmission : There is evidence that vaccinated individuals might shed spike proteins, Protein and DNA Repair : The Report cited studies showing the spike protein’s potential to interfere

protein and the renin-angiotensin system (RAS). He explained that both viral infection and vaccine-induced spike protein production may bind to the ACE2 He argued that certain structural features of the SARS-CoV-2 spike protein, including receptor-binding protein production due to manufacturing variability. of ACE2 binding or targeting alternative viral antigens such as nucleocapsid protein.

Witness Testimony Keywords from Transcript neurodegenerative disease research, spike protein toxicity protein toxicity, and potential long-term neurological risks. One Line Summary UBC neuroscientist raises concerns about spike protein neurotoxicity, biodistribution He discussed hypotheses regarding spike protein toxicity, neuroinflammation, microglial activation, and potential prion-like or amyloid-forming domains within the spike protein structure.

collapse case, pediatric death classification, glioblastoma palliative care, stillbirth investigation, spike protein testing denial, pregnancy vaccination counseling, informed consent discussions Included in the protein. intolerance after vaccination, a nurse with unilateral numbness lasting months, and an officer with persistent protein expression within Alberta.

Transcriptomics, mRNA Technology, Plasmid DNA Contamination, SB40 Promoter, Bacterial Plasmids, Antibiotic Resistance Pharmaceutical Standards, Gene Therapy Classification, Genomic Integration Concern, Biodistribution, Spike Protein Expression, Regulatory Oversight, Vaccine Safety, Mandates, Early Treatment Suppression Included genes, and variability in mRNA and spike protein fragments. products rather than conventional vaccines and raised concerns regarding potential genomic integration, persistence